Home page > Therapeutic Areas of Interest > Respiratory Medicine

Chiesi has been developing medicines to treat respiratory disease for more than 30 years. Thanks to modern treatments, patients with asthma or chronic obstructive pulmonary disease (COPD) have a better chance to live more active lives.



Asthma is a chronic inflammatory disease involving extreme hypersensitivity of the airways. The most common symptoms are coughing, wheezing, shortness of breath and tightness in the chest - usually intermittent, and unpredictable in duration and severity.


In Australia, around 2.7 million Australians (11% of the total population) have asthma1.


Apart from a genetic predisposition, asthma can have a wide variety of causes that can result in swelling of the mucous membranes, narrowing of the airways and increased mucus production.


Although the exact causes are unknown, asthma often occurs with other allergic conditions such as eczema and hay fever. Asthma attacks can be triggered for example, by pollen, dust, feathers, furry animals, exercise, viral infections, stress, chemicals and tobacco smoke.


Most people's asthma can usually be controlled by using medication which can help relieve symptoms or help prevent future symptoms and attacks.



Chronic obstructive pulmonary disease, or COPD, is the collective term for conditions such as chronic bronchitis and emphysema, which prevent people from breathing properly because the flow of air into the lungs is obstructed.


COPD is the third leading cause of death worldwide, causing 3.23 million deaths in 20192. The main cause is smoking, but it can also be caused by past exposure to fumes, chemicals and dust at work.


COPD is incurable because it causes permanent lung damage, but treatment and medication can help make breathing easier.



  1. 2017–2018 Australian Bureau of Statistics (ABS) National Health Survey (NHS) (ABS 2018); accessed 14 - www.abs.gov.au
  2. World Health Organisation (WHO) Global Health Estimates; accessed 14 July 2021 - www.who.int